News + Filings Charts Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jabbour Jerome D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Acquired 6,000 shares
@ $0
Converted 30,000 shares
@ $0
Converted 15 preferred shares
@ $0.5, valued at
$7.5 |
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Acquired 4,500 shares
@ $0 |
|
| 06/19/2020 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.815, valued at
$407.5k
|
|
| 03/18/2020 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Bought 10,000 shares
@ $0.65, valued at
$6.5k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2019 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Bought 14,650 shares
@ $0.6809, valued at
$10k
|
|
| 06/13/2019 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Bought 12,487 shares
@ $0.7992, valued at
$10k
|
|
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Bought 15 convertible preferred
@ $0.5, valued at
$7.5 |
|
| 03/23/2018 |
4
| Jabbour Jerome D (CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.98, valued at
$980k
|
|
| 03/01/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|